Author:
Zhang Chang,Wu Yang,Sun Yuna,Hong Chuan,Xiang Kehui,Guo Yu,Bartlam Mark,Lou Zhiyong
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Drug Discovery,Biochemistry,Biotechnology
Reference22 articles.
1. Andre, M., Morgeaux, S., and Fuchs, F. (2000). Quantitative detection of RTactivity by PERTassay: feasibility and limits to a standardized screening assay for human vaccines. Biologicals 28, 67–80.
2. Antoun, M.D., Rios, Y.R., Mendoza, N.T., and Proctor, G. (1994). Reverse transcriptase inhibition as prescreen for potential antiviral bioactives. P R Health Sci J 13, 17–18.
3. Arnold, B.A., Hepler, R.W., and Keller, P.M. (1998). One-step fluorescent probe product-enhanced reverse transcriptase assay. Biotechniques 25, 98–106.
4. Chang, A., Ostrove, J.M., and Bird, R.E. (1997). Development of an improved product enhanced reverse transcriptase assay. J Virol Methods 65, 45–54.
5. Clark, A.D., Jr., Jacobo-Molina, A., Clark, P., Hughes, S.H., and Arnold, E. (1995). Crystallization of human immunodeficiency virus type 1 reverse transcriptase with and without nucleic acid substrates, inhibitors, and an antibody Fab fragment. Methods Enzymol 262, 171–185.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献